D. E. Shaw & Co., Inc. is the biggest holder of Constellium N.V (CSTM)

Constellium N.V (NYSE:CSTM) reached 137.11% versus a 1-year low price of $4.95. The stock was last seen 10.58% higher, reaching at $11.5 on 10/26/2017. At recent session, the prices were hovering between $11.3 and $12.45. This company shares are -2.17% up from its target price of $11.25 and the current market capitalization stands at $1.21B. The recent change has given its price a 8.83% lead over SMA 50 and -1.71% deficit over its 52-week high. The stock witnessed 14.43% gains, 40.24% gains and 65.47% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CSTM’s volatility during a week at 4.24% and during a month it has been found around 4.07%.

Constellium N.V (CSTM) Top Holders

Institutional investors currently hold around $619 million or 73.1% in CSTM stock. Look at its top three institutional owners. D. E. Shaw & Co., Inc. owns $54.45 million in Constellium N.V, which represents roughly 4.5% of the company’s market cap and approximately 8.8% of the institutional ownership. Similar statistics are true for the second largest owner, Vaughan Nelson Investment Management, L.P., which owns 4,575,975 shares of the stock are valued at $47.59 million. The third largest holder is Jennison Associates Llc, which currently holds $38.73 million worth of this stock and that ownership represents nearly 3.2% of its market capitalization.

Constellium N.V 13F Filings

At the end of 06/30/2017 reporting period, 58 institutional holders increased their position in Constellium N.V (NYSE:CSTM) by some 8,342,926 shares, 64 decreased positions by 14,729,553 and 20 held positions by 36,406,271. That puts total institutional holdings at 59,478,750 shares, according to SEC filings. The stock grabbed 18 new institutional investments totaling 4,812,445 shares while 20 institutional investors sold out their entire positions totaling 6,130,072 shares.

Constellium N.V (CSTM) Analyst Guide

Several analysts have released their opinion on Constellium N.V (NYSE:CSTM), with 3 analysts believing it is a strong buy. Whereas 4 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.14 average brokerage recommendation.

Previous articleArrowhead Pharmaceuticals, Inc. (ARWR) held by 15 SEC 13F Filers
Next articleBarclays PLC (BCS) recently sold by insider Barclays Plc